Breaking News

HERMA US to Open Equipment Showroom & Testing Facility

August 10, 2016

NJ headquarters to feature HERMA 132M Wrap-Around Labeling Machine

HERMA US Inc., the newly-formed subsidiary of HERMA GmbH – a Germany-based provider of labeling machinery and self-adhesive labels & materials – is opening a showroom at its Fairfield, NJ headquarters. The space will allow the company to showcase its labeling machinery for the pharmaceutical industry, and will also be outfitted as a pre-delivery testing site for recently purchased machines.
 
Among the machines available for demonstration in the new showroom will be the HERMA 132M, a wrap-around, high speed labeling machine featuring a rotating star wheel for precise product transport. The HERMA 132M handles containers and glass bottles 16-80mm in diameter at speeds of up to 300 per minute. The machine can be outfitted with a range of printing and vision systems, and features automatic rejection of out-of-specification labels before they are applied to product. 
 
Peter Goff, president of HERMA US Inc., said, "The addition of a well-equipped demonstration and testing facility, in addition to the significant investment already made in the headquarters and warehouse facilities, furthers HERMA’s commitment to the U.S. market.  We are already seeing success with our HERMA 400 label applicator, which is widely acknowledged as a market leader.  The new facility allows us to showcase the advanced range of fully automatic labeling machinery produced by HERMA for the pharmaceutical industry and a variety of other sectors.”
  • Packaging Equipment Technology Preview

    Packaging Equipment Technology Preview

    February 15, 2017
    Today’s complex drug products present challenges; the latest equipment capabilities help overcome them

  • The Good, the Bad, and the Donald

    The Good, the Bad, and the Donald

    January 31, 2017
    Orphan drugs, CMO continuous manufacturing and developing world sales offer biggest revenue opportunities

  • Predictive Analytics and the Future of RBM

    Rajneesh Patil, Senior Director, RBM and Analytics, QuintilesIMS||January 23, 2017
    How advances in Risk-Based Monitoring will enable a more proactive approach to identify and mitigate potential risks